List of bibliographic references
Number of relevant bibliographic references: 4.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Female (MeSH) |
| 4 | Humans (MeSH) |
| 4 | Male (MeSH) |
| 4 | Middle Aged (MeSH) |
| 4 | Pandemics (MeSH) |
| 3 | Adolescent (MeSH) |
| 3 | Adult (MeSH) |
| 3 | Aged (MeSH) |
| 3 | Aged, 80 and over (MeSH) |
| 3 | Child, Preschool (MeSH) |
| 3 | Coronavirus Infections (mortality) |
| 3 | France (epidemiology) |
| 3 | Infant (MeSH) |
| 3 | Pneumonia, Viral (mortality) |
| 2 | Betacoronavirus (MeSH) |
| 2 | Betacoronavirus (genetics) |
| 2 | Child (MeSH) |
| 2 | Coronavirus Infections (diagnosis) |
| 2 | Coronavirus Infections (epidemiology) |
| 2 | Coronavirus Infections (virology) |
| 2 | Pneumonia, Viral (diagnosis) |
| 2 | Pneumonia, Viral (epidemiology) |
| 2 | Pneumonia, Viral (virology) |
| 2 | Time Factors (MeSH) |
| 2 | Viral Load (MeSH) |
| 2 | Young Adult (MeSH) |
| 1 | Age Factors (MeSH) |
| 1 | Antiviral Agents (administration & dosage) |
| 1 | Antiviral Agents (adverse effects) |
| 1 | Antiviral Agents (therapeutic use) |
| 1 | Asymptomatic Diseases (MeSH) |
| 1 | Azithromycin (administration & dosage) |
| 1 | Azithromycin (adverse effects) |
| 1 | Azithromycin (therapeutic use) |
| 1 | Betacoronavirus (isolation & purification) |
| 1 | Betacoronavirus (pathogenicity) |
| 1 | Clinical Laboratory Techniques (MeSH) |
| 1 | Clinical Laboratory Techniques (methods) |
| 1 | Coronavirus Infections (drug therapy) |
| 1 | Coronavirus Infections (physiopathology) |
| 1 | Diagnosis, Differential (MeSH) |
| 1 | Drug Therapy, Combination (MeSH) |
| 1 | Follow-Up Studies (MeSH) |
| 1 | France (MeSH) |
| 1 | Hydroxychloroquine (administration & dosage) |
| 1 | Hydroxychloroquine (adverse effects) |
| 1 | Hydroxychloroquine (therapeutic use) |
| 1 | Incidence (MeSH) |
| 1 | Infant, Newborn (MeSH) |
| 1 | Influenza A virus (MeSH) |
| 1 | Influenza, Human (epidemiology) |
| 1 | Nasopharynx (virology) |
| 1 | Pneumonia, Viral (drug therapy) |
| 1 | Pneumonia, Viral (physiopathology) |
| 1 | Polymerase Chain Reaction (MeSH) |
| 1 | Referral and Consultation (MeSH) |
| 1 | Respiratory Syncytial Virus Infections (epidemiology) |
| 1 | Retrospective Studies (MeSH) |
| 1 | Reverse Transcriptase Polymerase Chain Reaction (MeSH) |
| 1 | Severity of Illness Index (MeSH) |
| 1 | Sputum (virology) |
| 1 | Survival Analysis (MeSH) |
| 1 | Treatment Outcome (MeSH) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Christine Zandotti"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "Christine Zandotti" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Christine Zandotti
}}
| This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021 |  |
